Skip to main content
. Author manuscript; available in PMC: 2023 Jun 7.
Published in final edited form as: Acta Neuropathol. 2022 Dec 5;145(1):1–12. doi: 10.1007/s00401-022-02521-5

Table 1.

Subject clinical and demographic characteristics

Case# Age (years) Sex (M:F) PMI
(hours)
Clinical diagnosis NIH Biobank (source)
TSC TS 1 (TSC2) 30 M 3.0 Tuberous Sclerosis Maryland
TS 2 (TSC2) 34 F 5.0 Tuberous Sclerosis Maryland
TS 3 (N/A) 39 F 16.0 Tuberous Sclerosis Maryland
TS 4 (TSC2) 40 F 18.0 Tuberous Sclerosis Maryland
TS 5 (TSC2) 42 F 15.0 Tuberous Sclerosis Maryland
TS 6 (TSC1) 46 M 1.0 Tuberous Sclerosis Maryland
TS 7 (TSC2) 47 F 3.0 Tuberous Sclerosis Maryland
TS 8 (TSC2) 55 M 23.0 Tuberous Sclerosis Maryland
TS 9 (TSC2) 56 F 14.0 Tuberous Sclerosis Maryland
TS 10 (TSC2) 58 M 17.0 Tuberous Sclerosis Maryland
TS 11 (TSC2) 58 F 20.0 Tuberous Sclerosis Maryland
45.9 (SD) 4:7 12.2 (SD)
Epilepsy (non-TSC) EP 1 26 F 19.0 Epilepsy Maryland
EP 2 32 F 28.0 Epilepsy Maryland
EP 3 39 M 15.0 Epilepsy; Intellectual Disability NOS Maryland
EP 4 42 F 29.0 Epilepsy Maryland
EP 5 42 F 21.0 Epilepsy Maryland
EP 6 43 M 22.0 Epilepsy Maryland
EP 7 46 M 14.0 Epilepsy; Cerebrovascular Accident Maryland
EP 8 51 F 32.3 Epilepsy Harvard
EP 9 55 F 18.0 Epilepsy; ASD Maryland
41.8 (SD) 3:6 22.0 (SD)
Control Control 1 24 F 17.9 Alcohol abuse, BPD 1, cocaine abuse Miami
Control 2 34 M 26.7 Control Mt. Sinai
Control 3 41 F 10.7 Control Mt. Sinai
Control 4 42 M 6.0 Control Mt. Sinai
Control 5 43 F 21.5 MDD Miami
Control 6 45 F 24.5 BPD Mt. Sinai
Control 7 46 M 14.8 Control Mt. Sinai
Control 8 49 M 12.8 Control Mt. Sinai
Control 9 56 M 18.8 MDD Mt. Sinai
Control 10 58 M 16.8 Control Mt. Sinai
43.8 (SD) 6:4 17.0 (SD)

ASD, autism spectrum disorder; BPD, borderline personality disorder; MDD, major depressive disorder; NOS, not otherwise specified; TSC, Tuberous Sclerosis Complex; F, female; M, male; PMI, postmortem interval from death to autopsy; SD, standard deviation.